<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01402245</url>
  </required_header>
  <id_info>
    <org_study_id>411/E5/02</org_study_id>
    <secondary_id>383/E5/07</secondary_id>
    <nct_id>NCT01402245</nct_id>
  </id_info>
  <brief_title>Targeting of Immune Response After Pneumococcal Vaccination</brief_title>
  <acronym>PncHR</acronym>
  <official_title>Comparison of Immune Response in Pneumococcal Pneumonia and After Vaccination</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pneumococcal polysaccharide vaccine does not confer protection against noninvasive pneumonia.
      The study aims to compare lymphocyte homing in pneumonia and in those receiving Pnc
      polysaccharide vaccine (PPV) or Pnc conjugate vaccine (PCV)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pneumococcal polysaccharide vaccine does not confer protection against noninvasive pneumonia.
      The study compares the homing profiles of Pnc-specific plasmablasts in 15 patients with
      pneumonia and in 15 volunteers receiving Pnc polysaccharide vaccine (PPV) and 12 volunteers
      receiving Pnc conjugate vaccine (PCV)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2005</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Expression of homing receptors on circulating plasmablasts in Pnc pneumonia and after vaccination</measure>
    <time_frame>Day 0 and Day 7-10</time_frame>
    <description>HR on circulating Pnc-specific plasmablasts are determined in patients with pneumonia on day 7-10, in vaccinees on days 0 and 7</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Pneumococcal Pneumonia</condition>
  <arm_group>
    <arm_group_label>Pneumonia group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients with Pnc pneumonia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PPV Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Volunteers immunized with Pnc polysaccharide vaccine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCV Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Volunteers immunized with Pnc conjugate vaccine</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Pneumococcal polysaccharide vaccine</intervention_name>
    <description>Pneumococcal polysaccharide vaccine 0.5 ml i.m.</description>
    <arm_group_label>PPV Group</arm_group_label>
    <other_name>Pneumovax</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>pneumococcal conjugate vaccine</intervention_name>
    <description>pneumococcal conjugate vaccine 0.5 ml i.m.</description>
    <arm_group_label>PCV Group</arm_group_label>
    <other_name>Prevenar</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females ≥ 18 and &lt;65 years of age.

          -  General good health.

          -  Written informed consent.

          -  No previous vaccination against Pnc

          -  No previous history of Pnc pneumonia

          -  In pneumonia: Diagnosis of Pnc pneumonia within a week

        Exclusion Criteria:

          -  &lt; 18 years, ≥65 of age.

          -  In vaccinees: Acute disease at the time of enrollment.

          -  Pregnancy or lactation.

          -  Known immunodeficiency or immune suppressive treatment.

          -  Any chronic illness that might interfere with the immune response

          -  Alcohol or drug abuse

          -  Any clinically significant history of known or suspected anaphylaxis or
             hypersensitivity (based on the investigator's judgement).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anu Kantele, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Helsinki, Haartman institute, Dept. of Bacteriology and Immunology</name>
      <address>
        <city>Helsinki</city>
        <zip>00014</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Division of Infectious Diseases, HUCH</name>
      <address>
        <city>Helsinki</city>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Division of Microbiology, HUSLAB, Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Turku</name>
      <address>
        <city>Turku</city>
        <zip>20520</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>January 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 25, 2011</study_first_submitted>
  <study_first_submitted_qc>July 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 26, 2011</study_first_posted>
  <last_update_submitted>July 25, 2011</last_update_submitted>
  <last_update_submitted_qc>July 25, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 26, 2011</last_update_posted>
  <responsible_party>
    <name_title>Anu Kantele</name_title>
    <organization>Helsinki UYniversity Central Hospital</organization>
  </responsible_party>
  <keyword>pneumonia</keyword>
  <keyword>pneumococcal polysaccharide vaccine</keyword>
  <keyword>pneumococcal conjugate vaccine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pneumonia, Pneumococcal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
    <mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

